Physician

James V Lynott, MD

According to 2025 Medicare claims, James Lynott, MD (NPI: 1649277658) practices dermatology in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1083981906; TIN: 391351587) and primary practice location at 53406-4469.

Lynott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 770 traditional Medicare patients, billed 9,084 HCPCS/CPT codes, and received $701,747 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 2,570 prescription claims across 927 beneficiaries totaling $325,829 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2020 DME data shows 54 claims. Open Payments data shows 197 records totaling $3,322. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $219,506 to $325,829. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,192	10,265	$774,266
2016	1,138	10,342	$712,831
2017	1,099	10,945	$757,551
2018	1,219	11,785	$765,837
2019	1,086	10,468	$849,815
2020	846	10,016	$815,529
2021	847	10,971	$880,721
2022	860	10,053	$803,143
2023	825	9,379	$711,461
2024	770	9,084	$701,747

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	614	1,773	$219,506
2016	629	1,732	$243,440
2017	666	1,885	$235,956
2018	747	2,161	$184,702
2019	703	1,942	$113,020
2020	672	2,003	$139,590
2021	736	2,079	$120,646
2022	816	2,159	$317,633
2023	897	2,528	$519,441
2024	927	2,570	$325,829

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	54	54	$11,966
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	177	211	$449
11102	Biopsy of related skin growth, first growth	242	279	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	532	976	$62
17000	Destruction of precancer skin growth, 1 growth	500	807	$40
17003	Destruction of precancer skin growth, 2-14 growths	445	3,104	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	13	364	$97,456
Dupixent Pen	Dupilumab	13	364	$52,049
Doxycycline Monohydrate	Doxycycline Monohydrate	429	20,155	$10,540
Metronidazole	Metronidazole	121	3,359	$6,094
Triamcinolone Acetonide	Triamcinolone Acetonide	471	14,146	$5,506

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	197	$3,322	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James V. Lynott, MD?

Tedicare shows public-source Medicare data for James V. Lynott, MD (NPI 1649277658), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James V. Lynott, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James V. Lynott, MD?

James V. Lynott, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1083981906) in the available physician profile data.

Does James V. Lynott, MD have Open Payments data?

James V. Lynott, MD has 197 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.